U.S. Pharma Stock News

NYSE:BETA
NYSE:BETAAerospace & Defense

A Look At BETA Technologies (BETA) Valuation After Surf Air Deal And eVTOL Pilot Program Wins

BETA Technologies (BETA) is back in focus after Surf Air Mobility agreed to buy 25 ALIA CTOL aircraft, with options for up to 75 more, to launch commercial electric passenger services starting in Hawaii. See our latest analysis for BETA Technologies. The Surf Air Mobility deal follows a busy few weeks that included full year 2025 results, updated 2026 revenue guidance and selection for seven of eight federal eVTOL Integration Pilot Programs. Despite these developments, the share price remains...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Maplebear Fareway Deal Highlights Enterprise Tech Push And Marketplace Reach

Instacart parent Maplebear (NasdaqGS:CART) has partnered with Fareway to roll out an upgraded digital grocery experience using Storefront Pro and the Instacart Marketplace. The collaboration introduces no markup pickup orders and targets higher e commerce usage across Fareway’s 140+ stores in the Midwest. The partnership expands Maplebear’s enterprise commerce platform and extends its reach with a sizable regional grocer. For investors watching NasdaqGS:CART at a share price of $37.71, this...
NYSE:UNM
NYSE:UNMInsurance

Assessing Unum Group (UNM) Valuation After Recent Share Price Swings

Unum Group (UNM) is back on investors’ radar after recent share price swings, with short term returns mixed across the past week, month, and past 3 months. This has prompted closer attention to its fundamentals. See our latest analysis for Unum Group. At a share price of US$72.69, Unum Group’s recent moves include a 1-day share price return of 0.25% and a 30-day share price return of 1.32%. The year to date share price return of 5.88% and 1-year total shareholder return of 3.57% sit against a...
NYSE:UVV
NYSE:UVVTobacco

Assessing Universal (UVV) Valuation After Oversupply Pressures And Financing And Leadership Changes

Event overview and why Universal (UVV) is in focus Universal (UVV) is back on investors’ radar after management acknowledged that tobacco oversupply is affecting its core tobacco operations, while its ingredients diversification business recorded an operating loss in Q3 FY2026. To address these pressures, the company expanded its credit facility by US$250 million and appointed a new CFO. These steps reshape its financial flexibility and leadership profile at a time when both business segments...
NasdaqGS:CSGS
NasdaqGS:CSGSProfessional Services

CSG Systems International Buyout By NEC Puts Valuation Gap In Focus

CSG Systems International (NasdaqGS:CSGS) has agreed to be acquired by NEC Corporation. The deal marks a change in ownership that is expected to reshape how the company is positioned within the broader technology and communications sector. The acquisition terms center on CSG Systems International's current share price of $79.79 and its existing shareholder base. For current shareholders, this news follows a period in which NasdaqGS:CSGS has recorded a 36.7% return over 1 year, 64.1% over 3...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Lantheus Holdings (LNTH) Is Up 5.4% After New PYLARIFY TruVu And LUTATHERA Approvals - Has The Bull Case Changed?

Lantheus Holdings recently received FDA approval for PYLARIFY TruVu, an enhanced formulation of its PSMA PET imaging agent for prostate cancer, and tentative FDA approval for a radioequivalent version of LUTATHERA for somatostatin receptor–positive neuroendocrine tumors. These approvals build directly on the clinical evidence and commercial footprint of PYLARIFY, potentially strengthening Lantheus’s position across prostate and neuroendocrine tumor imaging while improving manufacturing...
NYSE:WH
NYSE:WHHospitality

A Look At Wyndham Hotels & Resorts (WH) Valuation After Its Higher Quarterly Dividend Announcement

Wyndham Hotels & Resorts (WH) just raised its quarterly cash dividend to US$0.43 per share, a 5% increase from 2025. This development puts the stock’s income profile firmly in focus for investors. See our latest analysis for Wyndham Hotels & Resorts. The higher dividend comes after a softer run in the stock, with a 7 day share price return of 7.5% and a 30 day share price return of 8.3%, while the 1 year total shareholder return is 14.4%. Longer term 3 and 5 year total shareholder returns of...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

What Do Perrigo’s (PRGO) Conference Remarks Reveal About Its Evolving Strategic Priorities?

Perrigo Company plc recently took part in the UBS Global Consumer and Retail Conference in New York, where President and CEO Patrick Lockwood-Taylor presented the company’s outlook and priorities to investors and industry participants. This conference appearance gave investors a direct window into management’s latest thinking on business focus, operational initiatives, and potential portfolio evolution, which can influence how the company’s longer-term position is understood. Next, we’ll...
NasdaqGS:TTAN
NasdaqGS:TTANSoftware

Stronger Results And New AI Leader Might Change The Case For Investing In ServiceTitan (TTAN)

ServiceTitan, Inc. recently reported fourth-quarter and full-year 2026 results showing higher revenue and a smaller net loss year-on-year, while issuing new revenue guidance for the coming quarter and fiscal year. The company also appointed Abhishek “Abhi” Mathur as Chief Technology and Product Officer, highlighting an intensified push to embed AI across its contractor-focused platform. Next, we’ll examine how Mathur’s AI-focused remit at ServiceTitan could influence the company’s existing...
NYSE:YALA
NYSE:YALAInteractive Media and Services

Yalla Group (YALA) Is Down 8.7% After Stronger Profits And New $150M Buyback Plan

In March 2026, Yalla Group Limited reported its fourth-quarter and full-year 2025 results, showing broadly stable revenue alongside higher net income and earnings per share, and issued first-quarter 2026 revenue guidance that factors in the timing of Ramadan. On the same day, Yalla unveiled a new 24‑month share repurchase program of up to US$150,000,000, following the completion of a prior buyback that retired just over 10% of its shares, signaling a continued focus on returning excess cash...
NYSE:OVV
NYSE:OVVOil and Gas

Assessing Ovintiv (OVV) Valuation After Operational Outperformance And Capital Return Moves

Why Ovintiv’s latest filing matters for shareholders Ovintiv (OVV) recently filed an omnibus shelf registration covering debt, common and preferred stock, warrants, units, and share purchase securities. This filing gives the company flexibility to raise capital through multiple instruments over time. See our latest analysis for Ovintiv. At a share price of $54.93, Ovintiv has seen a 30 day share price return of 17.80% and a year to date share price return of 35.66%, while the 5 year total...
NasdaqCM:IMPP
NasdaqCM:IMPPOil and Gas

Imperial Petroleum (IMPP) Is Up 11.6% After Q4 Earnings Beat And Preferred Dividend Declaration – Has The Bull Case Changed?

Imperial Petroleum Inc. recently reported fourth-quarter 2025 results, with sales of US$51.14 million and net income of US$14.96 million, and also declared a US$0.546875 preferred dividend on its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock for payment on March 30, 2026. While quarterly sales and earnings increased compared with the prior year’s quarter, full-year 2025 net income and earnings per share from continuing operations remained broadly in line with 2024 levels,...
NYSE:UCB
NYSE:UCBBanks

Is United Community Banks (UCB) Offering Value After Recent Share Price Weakness

If you are wondering whether United Community Banks is starting to look like good value, you are not alone, especially with the share price back on many investors' radar. The stock closed at US$30.18, with a 7 day return of 5.8% decline, a 30 day return of 14.7% decline, and a 1 year return of 12.7%, a mix that can change how investors see both its potential and its risks. Recent news coverage around United Community Banks has focused on its position within the regional banking sector and...
NasdaqGS:PLPC
NasdaqGS:PLPCElectrical

A Look At Preformed Line Products (PLPC) Valuation After Sales Growth And Profit Pressure

Preformed Line Products (PLPC) recently reported fourth quarter and full year 2025 results, showing higher net sales and a larger order backlog, alongside lower net income as tariffs and inventory adjustments weighed on profitability. See our latest analysis for Preformed Line Products. Preformed Line Products’ share price has climbed 23.08% year to date and its 1 year total shareholder return of 112.20% far outpaces the 90 day share price return of 12.54%. This suggests that momentum may...
NYSE:KSS
NYSE:KSSMultiline Retail

Is Kohl's (KSS) Share Slide Creating A Potential Value Opportunity For Investors

Wondering if Kohl's share price still reflects its true worth, or if the recent volatility has created a potential mispricing worth a closer look. The stock closed at US$13.27, with recent returns showing a 15.3% decline over 7 days and a 23.3% decline over 30 days, while the 1 year return sits at 68.4%. These swings sit against a longer backdrop where the 3 year return is a 29.8% decline and the 5 year return is a 70.3% decline. Short term moves can look very different from the longer track...
NYSE:HCI
NYSE:HCIInsurance

How Investors Are Reacting To HCI Group (HCI) Authorizing an $80 Million Share Buyback Program

On 3 March 2026, HCI Group, Inc. announced that its Board of Directors had authorized a one-year share repurchase program of up to US$80,000,000 of its common stock. This buyback authorization can be read as management choosing to allocate capital back to shareholders, potentially altering the company’s future capital structure and per-share metrics. We’ll now examine how HCI Group’s new US$80,000,000 repurchase authorization could influence its investment narrative and future capital...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

Trupanion HABRI Alliance Adds New Dimension To Pet Insurance Story

Trupanion (NasdaqGM:TRUP) announced a new partnership with the Human Animal Bond Research Institute (HABRI). The collaboration focuses on research and advocacy that supports the human and animal connection, including pet owners, veterans, service animals, and special populations. The initiative aims to use data driven insights to inform programs and policies that affect pet and human welfare. For you as an investor, this adds another layer to Trupanion's core pet insurance business. The...
NYSE:PATH
NYSE:PATHSoftware

UiPath (PATH) Profitability Milestone Tests Bearish Earnings Decline Narrative

UiPath (PATH) just posted its FY 2026 Q4 scorecard with revenue of US$481.1 million and basic EPS of US$0.19, alongside net income of US$104.5 million, putting a clear spotlight on how its automation platform is now feeding through to the bottom line. The company has seen quarterly revenue move from US$354.7 million in FY 2025 Q3 to US$423.6 million in FY 2025 Q4, then to US$356.6 million, US$361.7 million, US$411.1 million and now US$481.1 million in FY 2026 Q4. Basic EPS over those same...
NYSE:CLVT
NYSE:CLVTProfessional Services

Is Clarivate (CLVT) Pricing Catching Up After Recent 25.7% Share Price Jump?

This article walks through the key numbers so you can judge for yourself whether Clarivate's current share price reflects its true worth or if the market is still mispricing the story. Over the past month, Clarivate's share price is up 25.7%, although the stock still shows a 20.1% decline year to date and a 35.1% decline over the last year, with longer term returns over 3 and 5 years also in negative territory. Recent coverage around Clarivate has focused on its role as a data and analytics...
NYSE:KAI
NYSE:KAIMachinery

Is Kadant (KAI) Pricing Look Stretched After Recent Pullback In The Share Price

For investors wondering whether Kadant, at around US$321 per share, is priced for perfection or offering value, this article walks through what the numbers say about the stock. The share price is up 12.2% year to date. However, the past 7 days and 30 days show returns of 7.1% and 5.1% declines, and the 1 year return is a 4.5% decline, following a stronger 61.9% 3 year and 85.0% 5 year performance. Recent news coverage has focused on Kadant's role in capital goods markets and how investors...
NYSE:ABX
NYSE:ABXInsurance

Did Abacus Global Management's Earnings Turnaround Just Shift Abacus Global Management's (ABX) Investment Narrative?

Abacus Global Management, Inc. reported past fourth-quarter 2025 revenue of US$71.9 million, up from US$33.21 million a year earlier, and turned a prior net loss of US$18.26 million into net income of US$7.23 million, with basic earnings per share from continuing operations improving from a loss of US$0.22 to earnings of US$0.07. For 2025 as a whole, the company’s revenue more than doubled to US$235.24 million and it moved from a full-year net loss of US$23.96 million to net income of...
NYSE:OFG
NYSE:OFGBanks

A Look At OFG Bancorp’s (OFG) Valuation After Its New 2036 US$200 Million Bond Offering

Why the new 2036 bond matters for OFG Bancorp investors OFG Bancorp (OFG) has launched a US$200 million fixed to floating rate note offering due April 1, 2036, a move that could reshape its funding mix and draw attention to its capital structure. See our latest analysis for OFG Bancorp. The new 2036 notes come after a softer patch for the shares, with a 30 day share price return of 6.29% decline and year to date share price return of 4.44% decline. However, the 5 year total shareholder return...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Is Up 7.3% After CARVYKTI Reaches Profitability And 10,000 Patients Treated

In March 2026, Legend Biotech reported fourth-quarter 2025 revenue of US$306.3 million, up from US$186.5 million a year earlier, with an adjusted profit of US$0.01 per share but a GAAP net loss of US$30.9 million for the quarter and US$296.8 million for the full year on revenue of US$1.03 billion. The company’s CARVYKTI franchise reached more than 10,000 treated patients, achieved product-level profitability in 2025, and expanded to 294 treatment sites across 14 markets while scaling...
NYSEAM:BKTI
NYSEAM:BKTICommunications

BK Technologies (BKTI) Margin Expansion Reinforces Bullish Profitability Narratives

BK Technologies (BKTI) just posted fourth quarter FY 2025 revenue of US$21.5 million with basic EPS of US$1.12, alongside trailing 12 month revenue of US$86.1 million and EPS of US$3.69 that reflect the broader run rate coming into this report. The company has seen revenue move from US$17.9 million in Q4 2024 to US$21.5 million in Q4 2025, with basic EPS shifting from US$1.03 to US$1.12 over the same period, setting up a picture of earnings that feed into trailing 12 month net income of...